Results 201 to 210 of about 40,684 (247)

Case Report: IVC-agenesis and FVL mutation; successful DVT/PE treatment with direct oral anticoagulation (factor Xa inhibitor). [PDF]

Front Cardiovasc Med
Siddiqui A, Hatfield T, Nguyen Q, Waris W.   +3 more
europepmc   +1 more source

Investigating interassay variability between direct oral anticoagulant calibrated anti-factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trial. [PDF]

Res Pract Thromb Haemost
Baker RM, Selby R, Moffat KA, St John M, Spyropoulos AC, Schulman S, Douketis J.   +6 more
europepmc   +1 more source

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers. [PDF]

Front Pharmacol
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Czock D, Mikus G, Meid AD, Haefeli WE, Blank A.   +9 more
europepmc   +1 more source

Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage: The prospective observational multicenter ASTRO-DE study. [PDF]

Int J Stroke
Diener HC, Kuklik N, Hüsing A, Alonso A, Nabavi DG, Poli S, Gabriel MM, Maier IL, Grans J.   +8 more
europepmc   +1 more source

Direct Optical Detection of Factor Xa Activity in Minimally Processed Whole Blood

Cartwright AP, Wollant BC, York ES, Zheng L, Yee S, Chau HC, Batsuli G, Soh HT.   +7 more
europepmc   +1 more source

Perioperative Factor Xa Inhibitor Discontinuation for Patients Undergoing Procedures With Minimal or Low Bleeding Risk.

JAMA Netw Open
Lee SR, Lee KY, Park JS, Lee YS, Oh YS, Han SJ, Namgung J, Lee JH, Lim WH, Ahn MS, Kwon S, Ahn HJ, Oh S, Lip GYH, Choi EK, PERIXa Investigators.   +15 more
europepmc   +1 more source